Mining the Prognostic Role of DNA Methylation Heterogeneity in Lung Adenocarcinoma

Figure 4

The LUAD DNA methylation subtype-specific prognostic model has been validated: (a) the validation set’s area under the curve; (b) the validation set’s methylation profile of subtype-specific methylation sites; (c) the validation set’s prognosis differences; (d) a detailed survival analysis of each cluster comparison.

(a)

(b)

(c)

(d)